Holen Sie sich die Stockscreener-App
20.07
0.45%
-0.09
Handel nachbörslich:
20.07
Schlusskurs vom Vortag:
$20.16
Offen:
$20.26
24-Stunden-Volumen:
1.09M
Relative Volume:
1.31
Marktkapitalisierung:
$2.45B
Einnahmen:
$1.80B
Nettoeinkommen (Verlust:
$15.62M
KGV:
167.25
EPS:
0.12
Netto-Cashflow:
$118.36M
1W Leistung:
-2.76%
1M Leistung:
-8.15%
6M Leistung:
-11.51%
1J Leistung:
+2.35%
1-Tages-Spanne:
$20.02
$20.57
1-Wochen-Bereich:
$19.54
$21.10
52-Wochen-Spanne:
$16.47
$26.09
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Vergleichen Sie PRVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
20.07 | 2.52B | 1.80B | 15.62M | 118.36M | 0.12 |
|
VEEV
Veeva Systems Inc
|
285.20 | 45.64B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
61.08 | 9.68B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
97.41 | 8.32B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
59.38 | 11.63B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.57 | 6.57B | 906.14M | -52.62M | 89.62M | -0.3621 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-03 | Eingeleitet | Goldman | Buy |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-12-08 | Eingeleitet | UBS | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-05-03 | Eingeleitet | BofA Securities | Buy |
| 2022-04-28 | Eingeleitet | BTIG Research | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-01-03 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
| 2021-05-24 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-24 | Eingeleitet | Truist | Buy |
| 2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
What analysts say about Privia Health Group Inc. stockFree Stock Market Real-Time Monitoring - jammulinksnews.com
Is Privia Health Group Inc. a good long term investmentMarket-beating returns - jammulinksnews.com
Privia Health Group Inc. Stock Analysis and ForecastLightning-fast capital gains - Autocar Professional
What drives Privia Health Group Inc. stock priceRapid growth opportunities - jammulinksnews.com
Why Privia Health (PRVA) Stock Is Up Today - TradingView
why privia health group inc. stock attracts strong analyst attentionHigh Probability Setups - Newser
Envestnet Asset Management Inc. Decreases Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Relative Strength Alert For Privia Health Group - Nasdaq
Enovis, CONMED, Astrana Health, Privia Health, and Waters Corporation Stocks Trade Down, What You Need To Know - Yahoo.co
17,236 Shares in Privia Health Group, Inc. (NASDAQ:PRVA) Purchased by Teacher Retirement System of Texas - Defense World
(PRVA) Long Term Investment Analysis - news.stocktradersdaily.com
Why Privia Health Group Inc. stock attracts strong analyst attentionFree Access to Community with 300% Return - beatles.ru
How Privia Health Group Inc. stock performs during market volatilityFree Step-by-Step Investment Guide - Newser
What makes Privia Health Group Inc. stock price move sharplyLow Risk Trading Ideas - Newser
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by Bank of New York Mellon Corp - Defense World
Privia Health to Release Q2 2025 Earnings, Host Conference Call on August 7 - AInvest
Evercore ISI Lowers Privia Health Group (NASDAQ:PRVA) Price Target to $28.00 - Defense World
Privia Health to Report Second Quarter 2025 Results on Thursday, August 7 - The Manila Times
Privia Health Group, Inc. Announces Q2 2025 Financial Results Release Date and Conference Call Details - Quiver Quantitative
Privia Health to release Q2 results, host conference call on Aug. 7. - AInvest
Privia Health to Announce Q2 2025 Earnings on August 7 - AInvest
Privia Health Announces Q2 2025 Earnings Call: Key Details for August 7 Pre-Market Release - Stock Titan
Amalgamated Bank Has $659,000 Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
New York State Teachers Retirement System Decreases Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
GAMMA Investing LLC Purchases 1,521 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health appoints former Labcorp CTO to board of directors By Investing.com - Investing.com South Africa
Privia Health's Bold Bet on Cybersecurity: How Lance Berberian Could Turn the Tide in Healthcare Tech - AInvest
Privia Health Appoints Lance V. Berberian To Board - citybiz
Privia Health appoints former Labcorp CTO to board of directors - Investing.com
Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors - The Manila Times
Privia Health (PRVA) adds independent director, $200k RSU grant | SUP SEC FilingForm 8-K - Stock Titan
Privia Health (PRVA) adds independent director, $200k RSU grant | PRVA SEC FilingForm 8-K - Stock Titan
Healthcare Tech Expert Joins Privia Health Board: Former Labcorp CTO to Drive Digital Innovation - Stock Titan
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.86%
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):